Compared to [68Ga]Ga-PSMA-11 and [18F]DCFPyL, [18F]PSMA-1007 is mainly excreted via the hepatobiliary tract resulting in much lower urinary uptake and thus allows for improved evaluation of the pelvic area where most prostate cancer lesions are located [10,16,17]. Here, FOLH1 is linked to prostate carcinoma.